At Coxwell & Associates, located in Jackson, Mississippi, our medical negligence attorneys have exceptional experience in several types of pharmaceutical litigation claims. Some of these pharmaceutical litigation claims include the following products or medications.
Transvaginal Mesh Implants (TVM): This implant is used to treat pelvic organ prolapse and stress urinary incontinence in women. The implant is produced by several medical device manufacturers, including: Johnson & Johnson, CR Bard, American Medical Systems, and Boston Scientific. The Federal Drug Administration (FDA) states that 4,000 injury reports were filed between 2005 and 2010. Additionally, the failure rate for TVM is estimated to be as high as 10%.
Some common complications from a TVM can include: urinary problems, pain during sexual intercourse, recurrence of condition, inflammation and scarring, and mesh erosion through vaginal lining. The most common symptom to look for if you believe your TVM has failed is pelvic pain. Other common symptoms include unusual bleeding and a return of the underlying condition.
DePuy Hip Implants: Two major products from DePuy, the ASR Resurfacing System and the ASR XL Acetabular System are currently being recalled. The ASR is a metal on metal hip replacement system, which is believed to produce excessive metallic debris as it wears. This debris can cause serious inflammation, leading to damage in the surrounding muscle and soft tissue, which can compromise subsequent revision surgeries. Additionally, the metal on metal system can also create a condition called cobaltism, or an excessive amount of cobalt in the body. This condition can cause a variety of very serious symptoms, including: blindness, convulsions, headaches, vertigo, and deafness.
The National Joint Registry of England and Wales reports that within 5 years, 1 in 8 patients who received the recalled hip replacement will need a revision surgery. DePuy Orthopedics estimated that approximately 10,000 patients will need a revision surgery after receiving the recalled parts. Some symptoms to look for include difficulty walking, thigh pain, and pain when standing from a seated position.
Actos Injuries: Also known as Pioglitazone, this drug is used to treat Type II diabetes. It works by decreasing the amount of sugar in the blood and has been found to be most effective when used in combination with a lifestyle change. Some common side effects of this medication include upper respiratory tract infection, muscle aches, and headaches. One of the more severe side effects is fluid accumulation (edema), which can occur when the medication is combined with insulin. This fluid accumulation can lead to or worsen congestive heart failure. In 2010, the American Heart Association linked Actos with an increased risk of death from congestive heart failure.
There are many symptoms of congestive heart failure, including:
- Swelling of the hands or feet
- Unusual or sudden weight gain
- Trouble breathing during activity or while lying down
- Unusual fatigue
- Difficulty concentrating
- Swelling of the abdomen
- Rapid or irregular heart beat.
Byetta Injuries: Also known as Exenatide, this drug is an injectable diabetes medication used to control blood sugar levels in type II diabetics. This drug has been linked to pancreatic cancer and a 2011 study published in Gastroenterology reported that the use of Byetta increased the risk for pancreatic cancer by nearly three times. In March of 2013, the FDA announced it would investigate Byetta and the connection with pancreatic cancer.
Some of the symptoms of pancreatic cancer include:
- Abdominal pain (particularly a dull ache in the upper abdomen)
- Dark urine
- Loss of appetite
- Mild jaundice
- Unexplained weight loss
Reglan ™: Also known as metoclopramide, this drug is used to treat acid reflux and heartburn. Additionally, there are many “off label” uses of this drug, including the treatment of: pregnancy related nausea, morning sickness, lactation stimulation and migraine headache with nausea. The injectable form of Reglan has also been approved to treat nausea brought on by chemotherapy. The FDA has approved the use of Reglan for short-term use (1-3 months), but approximately 30% of patients are being prescribed the medication for a year or longer.
While there are some mild side effects associated with Reglan, the most concerning, and potentially permanent, is Tardive Dyskinesia. Involuntary movements, such as grimacing, rapid eye blinking, tongue protrusion, lip smacking, puckering, and pursing of the lips, characterize this condition. Rapid and involuntary movement of the torso, limbs, and fingers may also occur. This condition makes it incredibly difficult for an individual to remain still for any period of time. Tardive Dyskinesia is an incredibly debilitating condition that affects a person physically, emotionally, socially, and vocationally.
If you or a loved one has suffered from medical negligence in Jackson or anywhere in Mississippi, please contact the medical negligence attorneys at Coxwell & Associates, PLLC today to schedule your private consultation.